Device-makers with less-than-stellar compliance histories may soon be able to join a variation of a program offered by the US Food and Drug Administration that assesses a company's manufacturing maturity and quality.
The Case for Quality Voluntary Improvement Program (CFQ VIP) – run jointly by the agency and the Medical Device Innovation Consortium (MDIC) – aims to elevate product, manufacturing and process quality at device firms by appraising the companies against an industry-modified version of the